Literature DB >> 7921538

Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry.

L Y Yao1, C Moody, E Schönherr, T N Wight, L J Sandell.   

Abstract

Versican is a large chondroitin sulfate proteoglycan (CSPG) initially identified in cultured human fibroblasts. Previous studies have shown that there is a versican-like molecule in cultured monkey smooth muscle cells. In this study, we have cloned and sequenced the large CSPG from cultured monkey smooth muscle cells, fetal and juvenile monkey aorta, and human fetal aorta. The cDNA sequence from human fetal aorta is completely homologous to the human fibroblast versican. We obtained 2.5 kb of cDNA sequence from monkey aortic RNA and cultured monkey smooth muscle cell RNA. This sequence covers three distinct domains of versican (hyaluronic acid binding domain, glycosaminoglycan attachment domain and protein binding domain) and demonstrates over 90% homology to the human versican sequence. In situ hybridization histochemistry indicates that the versican RNA transcript is located in the epithelium throughout the tunica media of the aorta. Western blot analysis and immunohistochemistry also confirm the presence of versican in human and monkey aorta.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921538     DOI: 10.1016/0945-053x(94)90185-6

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  23 in total

1.  Mechanical properties of the extracellular matrix of the aorta studied by enzymatic treatments.

Authors:  Jan-Willem M Beenakker; Brian A Ashcroft; Jan H N Lindeman; Tjerk H Oosterkamp
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

2.  On the theory of reactive mixtures for modeling biological growth.

Authors:  Gerard A Ateshian
Journal:  Biomech Model Mechanobiol       Date:  2007-01-06

3.  Adamts5-/- Mice Exhibit Altered Aggrecan Proteolytic Profiles That Correlate With Ascending Aortic Anomalies.

Authors:  Loren E Dupuis; E Lockett Nelson; Brittany Hozik; Sarah C Porto; Alexandra Rogers-DeCotes; Amanda Fosang; Christine B Kern
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

Review 4.  Vascular extracellular matrix and arterial mechanics.

Authors:  Jessica E Wagenseil; Robert P Mecham
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

Review 5.  Integrins and vascular extracellular matrix assembly.

Authors:  E Ruoslahti; E Engvall
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

6.  Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.

Authors:  S P Evanko; E W Raines; R Ross; L I Gold; T N Wight
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

7.  The accumulation of versican in the nodules of benign prostatic hyperplasia.

Authors:  Lawrence D True; Sarah Hawley; Thomas H Norwood; Kathleen R Braun; Stephen P Evanko; Christina K Chan; Richard C LeBaron; Thomas N Wight
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

8.  Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.

Authors:  L R Tannock; P J Little; C Tsoi; P H R Barrett; T N Wight; A Chait
Journal:  Diabetologia       Date:  2004-04-08       Impact factor: 10.122

9.  Continuum modeling of biological tissue growth by cell division, and alteration of intracellular osmolytes and extracellular fixed charge density.

Authors:  Gerard A Ateshian; Kevin D Costa; Evren U Azeloglu; Barclay Morrison; Clark T Hung
Journal:  J Biomech Eng       Date:  2009-10       Impact factor: 2.097

10.  Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.

Authors:  N Wohner; Z Keresztes; P Sótonyi; L Szabó; E Komorowicz; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2010-04-20       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.